F-star Therapeutics (FSTX) Stock Highlights

7.12 | +0%

2023-04-13 19:43:19

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the companys goal is to offer patients greater and more durable benefits than immuno-oncology treatments.

Statistics

Range Today

7.12 7.12

Volume Today 0

Range 1 Year

2.07 7.12

Volume 1 Year 88.94M

Range 3 Year

0.81 15.5

Volume 3 Year 170.08M

Range 10 Year

0.8 18.93

Volume 10 Year 229.83M

Highlights

Market Capitalization 156.51M (small)

Floating Shares 21.58M

Current Price 7.12

Price To Earnings -3.89

Price To Revenue 6.31

Price To Book 2.75

Earnings Per Share -1.83

Payout Ratio 0%

Performance

Latest 0%

1 Month +45.01%

3 Months +33.08%

6 Months +18.47%

1 Year +97.23%

3 Years +691.11%

5 Years -53.13%

10 Years -36.88%

Benchmarks

Market Capitalization

239 / 368

Gross Profits

86 / 278

Total Revenue

163 / 300

Total Rank

130 / 368

Free Cashflow

138 / 352

Performance 5 years

174 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.